Floatz logo

Wellbutrin

Prostate Cancer Patients

Jiangsu HengRui Medicine Co., Ltd.Phase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Prostate Cancer Patients cohort.

Asset / SponsorPhaseRating
PHYTONADIONE, (E)-(±)-
Jiangsu HengRui Medicine Co., Ltd.
Phase 1CC
REPAGLINIDE
Jiangsu HengRui Medicine Co., Ltd.
Phase 1CC
Ptvg-Hp
University of Wisconsin, Madison
Phase 1CC

Same molecule, other indications

Wellbutrin is also rated in:

Smoking CessationDormant
A
Indicative ·
82 / 100
View asset →
DysthymiaDormant
BBB
Indicative ·
73 / 100
View asset →
depressive disorderDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →